Tenax Therapeutics (TENX) Return on Assets (2011 - 2026)
Tenax Therapeutics (TENX) posted quarterly Return on Assets of 0.02% for Q2 2026, down 1.0% year-over-year from 0.02% in Q2 2025, and down 36.75% on a QoQ basis from 0.01% in Q1 2026.
Tenax Therapeutics (TENX) Return on Assets (2011 - 2026) Analysis & Trends
Tenax Therapeutics has reported Return on Assets for 14 years, with the latest figure at 0.02% in Q2 2026.
- Return on Assets for Q2 2026 came in at 0.02%, down 1.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.02% (down 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
- Return on Assets slipped to 0.02% in Q2 2026, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q4 2022 and troughed at 0.12% in Q1 2022.
- A 5-year average of 0.02% and a median of 0.01% in 2025 frame the typical range for Return on Assets.
- The widest annual swing landed in 2022, when Return on Assets dropped 18 bps; it then advanced 13 bps in 2023.
- A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then slumped by 187 bps to 0.01% in 2023, then surged by 84 bps to 0.0% in 2024, then slumped by 243 bps to 0.01% in 2025, then plunged by 172 bps to 0.02% in 2026.
- Per Business Quant data, the three most recent Return on Assets figures were 0.02% in Q2 2026, 0.01% in Q1 2026, and 0.01% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Tenax Therapeutics | 80.73 Mn | 80.73 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.12% |
| Dec 31, 2021 | -0.04% |
| Sep 30, 2021 | 0.05% |